PFD report

JASON NOCK · Prevention of Future Deaths report

Pin Get email alerts Request correction

Issued 13 Jan 2014•Black Country

Report record

Published report and response evidence

This page connects the concerns raised in this report with statements found in recipients’ published responses. A link shows a clear evidence connection; it does not assign responsibility.

View original report
Concerns
4

Raised in this report

Recipients
1

Named on the report

Responses found
1

Of 1 recipient

Stated actions
9

Described in responses

Recipients and published responses

Source document

Full report text

This is the full text from the original published report.

Open published report

Concerns and recipient responses

Select any concern, action or position to view the source wording.

Concerns raised4

  1. Lack of product regulation
  2. Unrestricted availability of the product
  3. Lack of information about safe dosage and potential consequences
Responses linked to these concerns

Each statement is shown once, even when linked to more than one concern.

Actions described in response An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.5

  1. Action

    Monitor controlled drugs, new psychoactive substances and medicines offered for sale on the internet.

    Stated by Home OfficeStated in progressThe respondent said that this action was in progress when they made their response on 13 January 2014.
  2. Action

    Request independent expert advice on whether AH-7921 should be controlled under the Misuse of Drugs Act 1971.

    Stated by Home OfficeStated completedThe respondent said that this action was complete when they made their response on 13 January 2014.
  3. Action

    Work with European Union and international regulatory authorities to ensure offending websites reflect the law.

    Stated by Home OfficeStated in progressThe respondent said that this action was in progress when they made their response on 13 January 2014.

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of product regulation

Wider context from the report

“The matters of concern are that this product appears to be entirely unregulated, consumers do not know what they are taking, it is readily available to anyone with apparently little or no information as to safe dosage and potential consequences. ”

Is this part of a recurring concern?

No recurring-concern membership is currently published.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Unrestricted availability of the product

Wider context from the report

“The matters of concern are that this product appears to be entirely unregulated, consumers do not know what they are taking, it is readily available to anyone with apparently little or no information as to safe dosage and potential consequences. ”

Is this part of a recurring concern?

No recurring-concern membership is currently published.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Lack of information about safe dosage and potential consequences

Wider context from the report

“The matters of concern are that this product appears to be entirely unregulated, consumers do not know what they are taking, it is readily available to anyone with apparently little or no information as to safe dosage and potential consequences. ”

Is this part of a recurring concern?

No recurring-concern membership is currently published.

Open source report

Source evidence

How this individual concern was interpreted

PFD Monitor created a concise, searchable interpretation from the report wording shown below. Response links show a clear evidence connection; they do not assign responsibility.

PFD Monitor interpretation

Failure to provide consumers with information about product contents

Wider context from the report

“The matters of concern are that this product appears to be entirely unregulated, consumers do not know what they are taking, it is readily available to anyone with apparently little or no information as to safe dosage and potential consequences. ”

Is this part of a recurring concern?

No recurring-concern membership is currently published.

Open source report

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Monitor controlled drugs, new psychoactive substances and medicines offered for sale on the internet.

Verbatim wording from the response

“Action to restrict new psychoactive substance supply is a priority for UK law enforcement and other regulatory agencies. This activity includes the monitoring of controlled drugs, new psychoactive substances and medicines for sale on the internet and action with industry partners to close UK-based websites trading illegally in these substances. There is also ongoing work with the EU and other international regulatory authorities to ensure that, wherever possible, offending websites are amended to reflect the law.”

Source location

2014-0013-Response-by-Home-Office
Page 2 · response
Published 13 January 2014

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Request independent expert advice on whether AH-7921 should be controlled under the Misuse of Drugs Act 1971.

Verbatim wording from the response

“I note your request for further action to determine if AH-7921 should be made a controlled drug under the Misuse of Drugs Act 1971 and your concerns about its availability over the internet.”

Source location

2014-0013-Response-by-Home-Office
Page 1 · response
Published 13 January 2014

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Work with European Union and international regulatory authorities to ensure offending websites reflect the law.

Verbatim wording from the response

“Action to restrict new psychoactive substance supply is a priority for UK law enforcement and other regulatory agencies. This activity includes the monitoring of controlled drugs, new psychoactive substances and medicines for sale on the internet and action with industry partners to close UK-based websites trading illegally in these substances. There is also ongoing work with the EU and other international regulatory authorities to ensure that, wherever possible, offending websites are amended to reflect the law.”

Source location

2014-0013-Response-by-Home-Office
Page 2 · response
Published 13 January 2014

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Lead an expert-panel review of how the UK response to new psychoactive substances can be enhanced, including legal and policy options.

Verbatim wording from the response

“We know that there is more to be done in this area, especially given that the market continues to evolve with the rapid development of new drugs. For this reason, I am currently leading a review, being undertaken by an expert panel, to look at how the UK’s response to new psychoactive substances can be enhanced beyond existing measures. This will include considering the adequacy or otherwise of the Misuse of Drugs Act 1971 to deal with these new substances, but also what other policy levers, for example in health or education policy, might be available to Government. When I launched this review on the 27th February I highlighted my concerns regarding the availability of AH-7921 to the expert panel and media. The panel will report their findings in spring 2014. The terms of reference for the review can be found on the Home Office website.”

Source location

2014-0013-Response-by-Home-Office
Page 2 · response
Published 13 January 2014

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Work with industry partners to close UK-based websites trading these substances illegally.

Verbatim wording from the response

“Action to restrict new psychoactive substance supply is a priority for UK law enforcement and other regulatory agencies. This activity includes the monitoring of controlled drugs, new psychoactive substances and medicines for sale on the internet and action with industry partners to close UK-based websites trading illegally in these substances. There is also ongoing work with the EU and other international regulatory authorities to ensure that, wherever possible, offending websites are amended to reflect the law.”

Source location

2014-0013-Response-by-Home-Office
Page 2 · response
Published 13 January 2014

Open published response

Other statements in published responses

These actions and other statements could not be clearly connected to one concern in this report.

Recipient-stated actions An action is something a recipient says it has done, is doing, or plans to do in response to a concern raised.4

  1. 1

    Gather intelligence through the Forensic Early Warning System on online availability of AH-7921 and related substances.

    Stated by Home OfficeStated in progressThe respondent said that this action was in progress when they made their response on 13 January 2014.
  2. 2

    Continue government demand-reduction activity through the FRANK online service to raise awareness of risks from substances such as AH-7921.

    Stated by Home OfficeStated completedThe respondent said that this action was complete when they made their response on 13 January 2014.
  3. 3

    Collect evidence from health and law-enforcement organisations on AH-7921 and related substances.

    Stated by Home OfficeStated in progressThe respondent said that this action was in progress when they made their response on 13 January 2014.
  4. 4

    Publish the terms of reference for the review on the Home Office website.

    Stated by Home OfficeStated completedThe respondent said that this action was complete when they made their response on 13 January 2014.

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Gather intelligence through the Forensic Early Warning System on online availability of AH-7921 and related substances.

Verbatim wording from the response

“The Government shares your concerns regarding the unregulated sale of AH-7921. On the 12 December 2013, I asked our independent experts, the Advisory Council on the Misuse of Drugs (ACMD) to provide advice on AH-7921 and I am expecting to receive its recommendations in April. To ensure that the ACMD has the best available information, the Home Office is collecting evidence on AH-7921 and related substances from health organisations and law enforcement agencies and carrying out further work through our Forensic Early Warning System Project to gather intelligence regarding the availability of these substances online.”

Source location

2014-0013-Response-by-Home-Office
Page 1 · response
Published 13 January 2014

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Continue government demand-reduction activity through the FRANK online service to raise awareness of risks from substances such as AH-7921.

Verbatim wording from the response

“This work will continue to sit alongside other Government actions including our demand reduction activities, such as the FRANK online service which raises awareness of the risks of taking substances such as AH-7921.”

Source location

2014-0013-Response-by-Home-Office
Page 2 · response
Published 13 January 2014

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Collect evidence from health and law-enforcement organisations on AH-7921 and related substances.

Verbatim wording from the response

“The Government shares your concerns regarding the unregulated sale of AH-7921. On the 12 December 2013, I asked our independent experts, the Advisory Council on the Misuse of Drugs (ACMD) to provide advice on AH-7921 and I am expecting to receive its recommendations in April. To ensure that the ACMD has the best available information, the Home Office is collecting evidence on AH-7921 and related substances from health organisations and law enforcement agencies and carrying out further work through our Forensic Early Warning System Project to gather intelligence regarding the availability of these substances online.”

Source location

2014-0013-Response-by-Home-Office
Page 1 · response
Published 13 January 2014

Open published response

Source evidence

How this respondent action was interpreted

PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

PFD Monitor interpretation

Publish the terms of reference for the review on the Home Office website.

Verbatim wording from the response

“We know that there is more to be done in this area, especially given that the market continues to evolve with the rapid development of new drugs. For this reason, I am currently leading a review, being undertaken by an expert panel, to look at how the UK’s response to new psychoactive substances can be enhanced beyond existing measures. This will include considering the adequacy or otherwise of the Misuse of Drugs Act 1971 to deal with these new substances, but also what other policy levers, for example in health or education policy, might be available to Government. When I launched this review on the 27th February I highlighted my concerns regarding the availability of AH-7921 to the expert panel and media. The panel will report their findings in spring 2014. The terms of reference for the review can be found on the Home Office website.”

Source location

2014-0013-Response-by-Home-Office
Page 2 · response
Published 13 January 2014

Open published response
Back to top

Information checked against the published report and official responses · Data reviewed 7 Sep 2026 · About data quality and limitations

Data last updated 7 September 2026